No 10Y consistency score yet for revenue — the year-earlier revenue was zero, negative or too small a base to compare against in 40 of the 40 quarters in the window, leaving 0 comparable quarters; at least 28 are needed.
Valuation vs own 10Y history: P/S 175.9x · 10Y median 173.4x · 71st percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 40
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T14:01:51.766Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T14:01:51.766Z. Latest historical point 2023-11-13.
The latest delayed quote for GridAI Technologies Corp. (GRDX) stock was $3.96 as of Oct 6, 2026, 9:57 AM EDT, up 3.26% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -11.9% · 3-year avg -40.2%/yr · 5-year avg -83.8%/yr
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency.
Biotechnology · Edinburgh, FL
Next Earnings Date
Nov 16, 2026
41 days away
EPS Estimate
-11340.00
Revenue Est.
$85876.00
Last Quarter Results
EPS
$-0.44
vs Estimate
$-11340.00
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1GRDX | $28.20M | $3.96 | +3.26% | -11.92% | -83.84% | N/A | N/A |
| 2ATYR | $28.80M | $0.29 | +1.28% | -62.41% | N/A | N/A | vs GRDX |
| 3MCRB | $29.10M | $3.00 | +5.43% | -86.03% | -53.37% | -35.85% | vs GRDX |
| 4CRVO | $29.44M | $3.18 | -3.93% | -61.36% | -38.25% | -53.96% | vs GRDX |
| 5MDXH | $30.89M | $0.60 | +0.74% | -87.47% | N/A | N/A | vs GRDX |
| 6ATOS | $25.19M | $2.52 | +3.06% | -83.69% | -44.50% | -39.47% | vs GRDX |
forward FY estimate
N/A
$85876.00
vs Estimate
$85876.00
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$3.96
High
N/A
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-11340.00 | $-11340.00 | $-11340.00 | 1 |
| Quarter ending Dec 2026 | $-9450.00 | $-9450.00 | $-9450.00 | 1 |
| Quarter ending Mar 2027 | $-10080.00 | $-10080.00 | $-10080.00 | 1 |
| Quarter ending Jun 2027 | $-9534.00 | $-9534.00 | $-9534.00 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-5.22 | $-5.22 | $-5.22 | 1 |
| FY 2027 | $-4.95 | $-4.95 | $-4.95 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $85876.00 | $85876.00 | $85876.00 | 1 |
| Quarter ending Dec 2026 | $85876.00 | $85876.00 | $85876.00 | 1 |
| Quarter ending Mar 2027 | $85876.00 | $85876.00 | $85876.00 | 1 |
| Quarter ending Jun 2027 | $85876.00 | $85876.00 | $85876.00 | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $22.27M | $22.27M | $22.27M | 1 |
| FY 2027 | $27.51M | $27.51M | $27.51M | 1 |
